These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1136002)

  • 21. Prophylactic tranexamic acid decreases bleeding after cardiac operations.
    Horrow JC; Hlavacek J; Strong MD; Collier W; Brodsky I; Goldman SM; Goel IP
    J Thorac Cardiovasc Surg; 1990 Jan; 99(1):70-4. PubMed ID: 2403616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of antifibrinolytica on traumatic hyphaema and corneal oedema.
    Bramsen T
    Acta Ophthalmol Suppl; 1980; (145):1-53. PubMed ID: 6257028
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tissue fibrinolysis in the digestive mucosa. III. Treatment of ulcerative colitis by the direct administration of an antifibrinolytic agent as an enema (author's transl)].
    Kondo M; Fukumoto K; Yoshikawa T; Takemura S; Hotta T; Sugihara M; Furukawa Y; Matsuura S; Natsu K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Mar; 78(3):653-7. PubMed ID: 7253294
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of an antifibrinolytic agent (tranexamic acid) and lateral sutures with laser conization of the cervix.
    Grundsell H; Larsson G; Bekassy Z
    Obstet Gynecol; 1984 Oct; 64(4):573-6. PubMed ID: 6384851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention and treatment of IUD-induced menorrhagia with antifibrinolytic and antiprostaglandin drugs].
    Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):291-4, 312. PubMed ID: 3443023
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the fibrinolytic system in experimental atheromatosis].
    Lasierra J; Díez MM; Capetillo MA; Viladés E; Gracia A; Aznar López J; Piñero J; López Campos JL; Bermudo F; Cobo R
    Sangre (Barc); 1982; 27(6):1018-29. PubMed ID: 6764034
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tranexamic acid in the prevention of oropharyngeal radiomucositis].
    Mevio E; Santarelli P
    Radiol Med; 1983 May; 69(5):325-6. PubMed ID: 6658041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.
    Puigdellívol E; Carral ME; Moreno J; Plà-Delfina JM; Jané F
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):298-301. PubMed ID: 4018929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neonatal antihemorrhagic treatment with tranexamic acid].
    Panizza GF; Luxardo P; Zamboni G; Di Stefano S; Capra E
    Minerva Pediatr; 1976 Feb; 28(6):345. PubMed ID: 1256416
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M
    Rinsho Ketsueki; 1972 Feb; 13(1):30-7. PubMed ID: 4281839
    [No Abstract]   [Full Text] [Related]  

  • 32. Tranexamic acid.
    Med Lett Drugs Ther; 1987 Sep; 29(749):89-90. PubMed ID: 3626975
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tranexamic acid and thrombosis of the superior longitudinal sinus].
    Humbert P; Gutknecht J; Mallet H; Dupond JL; Leconte des Floris R
    Therapie; 1987; 42(1):65-6. PubMed ID: 3590072
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endoscopic hemostasis in hemorrhagic peptic ulcer. A review and pilot study of local thrombin injection combined with systemic fibrinolysis inhibition (with tranexamic acid)].
    Stallemo A; Bang C; Børkje B; Hausken T; Pedersen R; Odegaard S; Berstad A
    Tidsskr Nor Laegeforen; 1990 Feb; 110(4):497-500. PubMed ID: 2408191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of tranexamic acid as an antiflogistic in oral surgery].
    Pappalardo G; Caltabiano M; Bella G; Cicciù D
    Riv Ital Stomatol; 1981; 50(5):391-6. PubMed ID: 6949263
    [No Abstract]   [Full Text] [Related]  

  • 36. Spectrofluorometric determination of tranexamic acid in pharmaceutical dosage forms.
    Iskender G; Atmaca S
    Pharmazie; 1988 Apr; 43(4):290. PubMed ID: 3413222
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of tranexamic acid on pulmonary tissue fibrinolysis in the rat.
    Risberg B
    Microvasc Res; 1976 May; 11(3):307-14. PubMed ID: 933860
    [No Abstract]   [Full Text] [Related]  

  • 38. Fibrinolytic activity in CSF of patients with SAH in the acute phase measured by a rapid method (correlation with t-AMCA concentration in CSF.
    Nishimatsu T; Shibasaki T; Sasaki H; Nukui H
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):85-93. PubMed ID: 6168953
    [No Abstract]   [Full Text] [Related]  

  • 39. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranexamic acid derivatives with enhanced absorption.
    Svahn CM; Merenyi F; Karlson L; Widlund L; Grälls M
    J Med Chem; 1986 Apr; 29(4):448-53. PubMed ID: 3959024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.